Delivery Order SPE2DE24DA017-SPE2D625F3JGA
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,597.76 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025. This fixed-price delivery order with economic price adjustment is for an ANGEL CPRP (Autologous Neovasculogenic Growth Factor) Processing Set and does not utilize a set-aside designation. The contract is to be completed by September 15, 2025, with performance occurring...
- Arthrex Inc., headquartered in Naples, Florida, was awarded a delivery order valued at $3,219.48 for the ARTHREX ANGEL PRP Kit (US Tray) on September 2, 2025, with an ultimate completion date of September 5, 2025. This fixed-price delivery order with economic price adjustment was funded through the Defense Logistics Agency's Medical Supply Chain and will be performed at Arthrex's Naples, Florida facility. The award represents a competitive procurement with no set-aside designation, reflecting...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,577.20 on August 18, 2025, for the supply of ARTHREX ANGEL PRP Kits (US Tray). The contract, which utilizes fixed-price pricing with economic price adjustment terms, is scheduled for completion by August 21, 2025, and will be performed at Arthrex's Naples, Florida location. The award carries no set-aside designation, reflecting the company's strong...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a fixed-price delivery order valued at $35,772 from the Defense Logistics Agency's Medical Supply Chain on August 14, 2025, for the ARTHREX ANGEL PRP Kit (US Tray). The contract, which carries an ultimate completion date of August 19, 2025, was awarded without a set-aside designation, reflecting Arthrex's competitive strength in the federal orthopedic medical device marketplace. The...
- Arthrex Inc., headquartered in Naples, Florida, was awarded a delivery order valued at $14,308.80 by the Defense Logistics Agency's Medical Supply Chain on August 27, 2025, with an ultimate completion date of September 2, 2025. This fixed-price contract with economic price adjustment provisions covers the supply of ARTHREX ANGEL PRP Kits in U.S. trays, which are advanced orthopedic medical devices used in minimally invasive surgical procedures. The contract carries no set-aside designation,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a fixed-price delivery order valued at $3,577.20 from the Defense Logistics Agency's Medical Supply Chain on August 1, 2025, with an ultimate completion date of August 6, 2025. The delivery order covers the Arthrex ANGEL PRP Kit for the U.S. market, a specialized medical device used in orthopedic procedures. This award was not set aside for any specific business category, reflecting...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a delivery order from the Defense Logistics Agency's Medical Supply Chain on August 1, 2025, for the supply of ARTHREX ANGEL PRP Kits. This fixed-price delivery order, valued at $12,475.65 with economic price adjustment provisions, is scheduled for completion by August 6, 2025, and will be fulfilled at the company's Naples facility. The contract was awarded without any set-aside designation, reflecting...
- Arthrex Inc., headquartered in Naples, Florida, was awarded a delivery order valued at $9,262.44 on August 15, 2025, for the supply of ARTHREX ANGEL PRP Kit (US Tray). This fixed-price contract with economic price adjustment is a non-set-aside award with an ultimate completion date of August 20, 2025, and will be performed in Naples, FL. The delivery order is issued under the Defense Logistics Agency's Medical Supply Chain, which procures specialized medical equipment and orthopedic technologies...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $18,183.64 by the Defense Logistics Agency's Medical Supply Chain on September 4, 2025. The delivery order, which carries a fixed-price contract type with economic price adjustment provisions, covers the supply of Arthrex ANGEL PRP Kits (US Tray) with a completion date of September 9, 2025. This award was not set aside for any specific business category,...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, received a $8,943 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, for the ARTHREX ANGEL PRP Kit (US Tray). The delivery order, which carries an ultimate completion date of July 30, 2025, was awarded without set-aside designation, reflecting Arthrex's strong competitive standing in the federal marketplace. The work will be performed in Naples,...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F3JGADelivery Order
Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, has been awarded a delivery order valued at $3,670.92 for an ANGEL CPRP Processing Set under a fixed-price contract with economic price adjustment terms. The award was issued on September 12, 2025, with an ultimate completion date of September 17, 2025, and will be performed in Naples, Florida. This delivery order was not subject to any small business set-aside and was funded through the Defense Logistics Agency's Medical Supply Chain, which serves the Department of Defense. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and extending through September 2029. The parent IDC enables VA medical centers and military healthcare facilities nationwide to procure Arthrex's comprehensive portfolio of orthopedic surgical products, including arthroscopic instruments, surgical implants, suture anchors, joint replacement systems, and specialized surgical kits. The ANGEL CPRP (Autologous Protein Rich Plasma) processing equipment represents Arthrex's capability to supply advanced biologics and regenerative medicine technologies to support orthopedic surgical procedures across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/12/25 |